Diverse metabolic response of cancer cells treated with a (213)Bi-anti-EGFR-immunoconjugate

Evaluation of treatment response is among the major challenges in modern oncology. We herein used a monoclonal antibody targeting the EGF receptor (EGFR) labelled with the alpha emitter (213)Bi ((213)Bi-anti-EGFR-MAb). EJ28Luc (bladder) and LN18 (glioma) cancer cells, both overexpressing EGFR, were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Feuerecker, Benedikt, Biechl, Philipp, Seidl, Christof, Bruchertseifer, Frank, Morgenstern, Alfred, Schwaiger, Markus, Eisenreich, Wolfgang
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7973706/
https://ncbi.nlm.nih.gov/pubmed/33737524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-84421-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados